| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/03/2013 | EP2608799A2 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| 07/03/2013 | EP2608794A1 Methods and compositions for preventing or treating obesity |
| 07/03/2013 | EP2608780A1 Improved enteric active substance delivery |
| 07/03/2013 | EP2608777A2 Compositions and methods for cardiac therapy |
| 07/03/2013 | EP2608771A1 Compositions for gastric delivery of active agents |
| 07/03/2013 | EP2608681A1 Nutritional products having improved organoleptic properties |
| 07/03/2013 | CN103189748A Fertilization prediction and promotion |
| 07/03/2013 | CN103189511A Method for producing novel hiPSC by means of siRNA introduction |
| 07/03/2013 | CN103189510A TTLL4 peptides and vaccines containing the same |
| 07/03/2013 | CN103189072A Novel immunostimulatory method |
| 07/03/2013 | CN103189070A Method to increase the absorption of unsaturated fatty acids by human infants |
| 07/03/2013 | CN103189069A Treatment of neurodegenerative diseases by targeting miRNA |
| 07/03/2013 | CN103189068A Compositions for drug administration |
| 07/03/2013 | CN103189067A Inhibition of WDR5 interaction with its binding partners and therapeutic methods |
| 07/03/2013 | CN103189051A Microparticles comprising a small heat-shock protein |
| 07/03/2013 | CN103189050A Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| 07/03/2013 | CN103184234A Tumor antigens BFA5 for prevention and/or treatment of cancer |
| 07/03/2013 | CN103184209A Homosapiensarginase and pegylation homosapiensarginase as well as applications thereof |
| 07/03/2013 | CN103184208A Homosapiensarginase and fixed-point pegylation homosapiensarginase as well as applications thereof |
| 07/03/2013 | CN103184207A Agkistrodon acutus streptokinase and preparation method and application thereof |
| 07/03/2013 | CN103184202A A pair of short peptides, proteins and polynucleotides, host cells and applications thereof |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183723A 新颖的尿苷肽类抗生素及其用途 Uridine novel peptide antibiotics and their use |
| 07/03/2013 | CN103183722A Glyoxalase I inhibitor, preparation method and medical application thereof |
| 07/03/2013 | CN103182092A Bone generation by gene therapy |
| 07/03/2013 | CN103182089A Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene |
| 07/03/2013 | CN103182075A Lysozyme preparation, preparation method thereof, and application thereof |
| 07/03/2013 | CN103182074A Ophthalmic preparation containing lysozyme |
| 07/03/2013 | CN103182073A Pharmaceutical injection of recombinant human interferon alpha-CTP fusion protein |
| 07/03/2013 | CN103182072A Application of interleukin-22 in treating and preventing nerve injuries and neurodegeneration diseases |
| 07/03/2013 | CN103182071A Method for building mouse severe aplastic anemia model |
| 07/03/2013 | CN103182070A External composition, and preparation and application thereof |
| 07/03/2013 | CN103182069A 荷电的脂蛋白络合物及其用途 Charged lipoprotein complexes and their use |
| 07/03/2013 | CN103182068A Application of cyclic lipopeptide Fengycin in preparation of antineoplastic drug |
| 07/03/2013 | CN103182067A Application of pidotimod as immune enhancer on livestock and poultry |
| 07/03/2013 | CN103181565A PM2.5-preventing capsule for clearing away lung toxicant and protecting lungs |
| 07/03/2013 | CN103181564A Nutritional composition for immune condition |
| 07/03/2013 | CN102552886B Oral superoxide dismutase (SOD) capsules having anti-oxidation effect and preparation method thereof |
| 07/03/2013 | CN102335414B Preparation method of rice prolamin bile acid adsorbent |
| 07/03/2013 | CN102241737B Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines |
| 07/03/2013 | CN101987200B Compound medicine containing antihypertensive peptide and aldosterone receptor antagonist for curing hypertension |
| 07/03/2013 | CN101935341B Polypeptide with activity of inhibiting beta-lactamase and preparation method and application thereof |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101516969B Targeted polylysine dendrimer therapeutic agent modified macromolecule 2 |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101268102B Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI) -anchors for treatment of cancer and skin lesions |
| 07/02/2013 | US8476418 Modified AAV capsid polypeptides |
| 07/02/2013 | US8476405 Neuregulin variants and methods of screening and using thereof |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 07/02/2013 | US8476254 Methods for treating psychosis associated with interferson-α therapy |
| 07/02/2013 | US8476249 Method of treating thrombocytopenia |
| 07/02/2013 | US8476245 Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes |
| 07/02/2013 | US8476240 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 07/02/2013 | US8476239 Stable protein formulations |
| 07/02/2013 | US8476238 Uses of an immunomodulatory protein (GMI) from Ganoderma microsporum |
| 07/02/2013 | US8476237 Compositions and methods for treating cancer by inhibiting the secretion of microparticles |
| 07/02/2013 | US8476236 Treatment of skin conditions by Dickkopf1 (DKK1) |
| 07/02/2013 | US8476235 Crystalline D-isoglutamyl-D-tryptophan and the mono ammonium salt of D-isoglutamyl-D-tryptophan |
| 07/02/2013 | US8476234 Long-acting coagulation factors and methods of producing same |
| 07/02/2013 | US8476233 Methods for treatment for ulcerative colitis in mammals |
| 07/02/2013 | US8476232 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 07/02/2013 | US8476231 Conditioned cell culture medium compositions and methods of use |
| 07/02/2013 | US8476230 Insulinotropic complex using an immunoglobulin fragment |
| 07/02/2013 | US8476229 Blood sugar-modulating polypeptides |
| 07/02/2013 | US8476228 Insulin derivatives |
| 07/02/2013 | US8476227 Methods of activating a melanocortin-4 receptor pathway in obese subjects |
| 07/02/2013 | US8476225 Antiviral compounds |
| 07/02/2013 | US8476224 Macrocycles and their uses |
| 07/02/2013 | US8476223 Metallo-lactoferrin-coenzyme compositions to improve sleep patterns |
| 07/02/2013 | US8476222 Isolated peptides from Actinomadura namibiensis |
| 07/02/2013 | US8476221 Methods and compositions for the treatment of metabolic disorders |
| 07/02/2013 | US8476054 Thrombin-like enzyme of Agkistrodon acutus |
| 07/02/2013 | US8476039 Hot spring bacterial strain BKH1 and protein isolated therefrom, concrete compositions, and uses thereof |
| 07/02/2013 | US8476024 Botulinum neurotoxin a protein receptor and uses thereof |
| 07/02/2013 | US8476010 Propofol formulations with non-reactive container closures |
| 07/02/2013 | US8475834 Method of improving absorption of vitamin E by a pet animal |
| 07/02/2013 | US8475831 Treatment of ophthalmic conditions |
| 07/02/2013 | US8475812 Gelatin sponge comprising an active ingredient, its preparation and use |
| 07/02/2013 | US8475802 Peptide sequences and compositions |
| 07/02/2013 | US8475800 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475791 Anti-IL-TIF antibodies and methods of use |
| 07/02/2013 | US8475784 IL-21 variants |
| 07/02/2013 | US8475779 Methods of treating disease with random copolymers |
| 07/02/2013 | US8475765 Hydroxyalkyl starch derivatives |
| 07/02/2013 | CA2725513C Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer |
| 07/02/2013 | CA2649134C Synthesis of sialic acid in plants |
| 07/02/2013 | CA2608019C Use of histones to treat thrombocytopenia |
| 07/02/2013 | CA2601360C Sclerostin and the inhibition of wnt signaling and bone formation |
| 07/02/2013 | CA2576419C Enzyme inhibitor in leukemia |
| 07/02/2013 | CA2522890C Method for selective inhibition of human n-myc gene in n-myc expressing tumors through anti-sense and sense peptide nucleic acids |
| 07/02/2013 | CA2519975C Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 07/02/2013 | CA2505558C T cell receptor display |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 07/02/2013 | CA2501870C Single chain recombinant t cell receptors |
| 07/02/2013 | CA2277778C Specific pancreatic lipase inhibitors and their applications |
| 07/02/2013 | CA2251009C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/27/2013 | WO2013096940A1 Double binding constructs |
| 06/27/2013 | WO2013096939A1 Selective binding compounds |
| 06/27/2013 | WO2013096912A2 Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase |